St. Jude Medical calls another halt to its Nanostim clinical trial program in the U.S. and Europe after serious adverse events surfaced in several patients.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1PL5KKt
Cap comentari:
Publica un comentari a l'entrada